Nathan Newman, who supported the Faustian Prescription Drug Deal, is right to argue that the increase in projected costs presents the Democrats an opportunity to call for the corporate sweetheart deals built into the legislation to be reversed – to make this an object lesson in which party it is that’s breaking the bank, and where the cash is going. Here’s hoping the Democrats indeed take the chance to take a stand. They still would have been better off taking a stand against the damn thing when it was time to vote in the first place.